The quest for potent therapies demands identification of new therapeutic approaches. This analysis explores recent advancements in identifying and establishing such objectives – moving beyond conventional pathways to confront unmet clinical needs. Particularly , we consider targets involved in complex disease mechanisms , including disruptions in